Free Trial
NASDAQ:ENTX

Entera Bio (ENTX) Stock Price, News & Analysis

Entera Bio logo
$1.95 +0.04 (+2.09%)
As of 07/3/2025 03:26 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Entera Bio Stock (NASDAQ:ENTX)

Key Stats

Today's Range
$1.88
$1.96
50-Day Range
$1.82
$2.36
52-Week Range
$1.41
$2.79
Volume
18,161 shs
Average Volume
67,467 shs
Market Capitalization
$88.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.00
Consensus Rating
Buy

Company Overview

Entera Bio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
53rd Percentile Overall Score

ENTX MarketRank™: 

Entera Bio scored higher than 53% of companies evaluated by MarketBeat, and ranked 503rd out of 929 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Entera Bio has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Entera Bio has received no research coverage in the past 90 days.

  • Read more about Entera Bio's stock forecast and price target.
  • Earnings Growth

    Earnings for Entera Bio are expected to decrease in the coming year, from ($0.28) to ($0.55) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Entera Bio is -7.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Entera Bio is -7.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Entera Bio has a P/B Ratio of 8.48. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Entera Bio's valuation and earnings.
  • Percentage of Shares Shorted

    0.18% of the float of Entera Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Entera Bio has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Entera Bio has recently decreased by 9.47%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Entera Bio does not currently pay a dividend.

  • Dividend Growth

    Entera Bio does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.18% of the float of Entera Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Entera Bio has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Entera Bio has recently decreased by 9.47%, indicating that investor sentiment is improving significantly.
    • Insider Buying vs. Insider Selling

      In the past three months, Entera Bio insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      10.38% of the stock of Entera Bio is held by insiders. A high percentage of insider ownership can be a sign of company health.

    • Percentage Held by Institutions

      Only 14.11% of the stock of Entera Bio is held by institutions.

    • Read more about Entera Bio's insider trading history.
    Receive ENTX Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Entera Bio and its competitors with MarketBeat's FREE daily newsletter.

    ENTX Stock News Headlines

    Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps
    Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
    Entera Bio Reports Transformative Year in 2024
    See More Headlines

    ENTX Stock Analysis - Frequently Asked Questions

    Entera Bio's stock was trading at $2.12 at the start of the year. Since then, ENTX shares have decreased by 8.0% and is now trading at $1.95.

    Entera Bio Ltd. (NASDAQ:ENTX) issued its quarterly earnings data on Friday, May, 9th. The company reported ($0.06) earnings per share for the quarter, beating analysts' consensus estimates of ($0.07) by $0.01. The business had revenue of $0.04 million for the quarter. Entera Bio had a negative trailing twelve-month return on equity of 95.10% and a negative net margin of 4,525.11%.

    Entera Bio (ENTX) raised $11 million in an initial public offering on Thursday, June 28th 2018. The company issued 1,400,000 shares at $8.00 per share. Maxim Group served as the underwriter for the IPO and Joseph Gunnar was co-manager.

    Shares of ENTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Entera Bio investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Advanced Micro Devices (AMD), CymaBay Therapeutics (CBAY) and GE Aerospace (GE).

    Company Calendar

    Last Earnings
    5/09/2025
    Today
    7/05/2025
    Next Earnings (Estimated)
    8/08/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    MED - BIOMED/GENE
    Sub-Industry
    Pharmaceutical Products
    Current Symbol
    NASDAQ:ENTX
    Fax
    N/A
    Employees
    20
    Year Founded
    N/A

    Price Target and Rating

    Average Stock Price Target
    $10.00
    High Stock Price Target
    $10.00
    Low Stock Price Target
    $10.00
    Potential Upside/Downside
    +412.8%
    Consensus Rating
    Buy
    Rating Score (0-4)
    3.00
    Research Coverage
    1 Analysts

    Profitability

    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    -$9.54 million
    Net Margins
    -4,525.11%
    Pretax Margin
    -4,518.83%

    Debt

    Sales & Book Value

    Annual Sales
    $180 thousand
    Price / Cash Flow
    N/A
    Book Value
    $0.23 per share
    Price / Book
    8.48

    Miscellaneous

    Free Float
    40,734,000
    Market Cap
    $88.63 million
    Optionable
    Optionable
    Beta
    1.46
     The Best Nuclear Energy Stocks to Buy Cover

    Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

    Get This Free Report

    This page (NASDAQ:ENTX) was last updated on 7/5/2025 by MarketBeat.com Staff
    From Our Partners